Viemed Healthcare (VMD) CFO logs RSU vesting, tax share withholding in Form 4

Rhea-AI Filing Summary

Viemed Healthcare Chief Financial Officer Fitzgerald Trae reported equity award activity involving restricted stock units, phantom share units, and common shares on January 21, 2026. A block of 13,317 restricted stock units vested and converted into common shares, with 4,246 of those shares withheld by the company to cover taxes at a per-share value of $7.49, leaving 98,523 common shares directly held after the transactions. In addition, 3,329 cash-settled phantom share units vested under the company’s Phantom Share Unit Plan, which were economically equivalent to common shares and were settled in cash through a matched acquisition and disposition of 3,329 underlying common shares. Following these events, Trae held 26,632 restricted stock units and 6,658 phantom share units, each unit tied to one common share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fitzgerald Trae

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/21/2026		M		13,317	A	(1)	102,769	D
Common Shares	01/21/2026		F		4,246(2)	D	$7.49(3)	98,523	D
Common Shares	01/21/2026		M		3,329	A	(4)	101,852	D
Common Shares	01/21/2026		D		3,329	D	$7.49(3)	98,523	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/21/2026		M			13,317	(5)	01/21/2028	Common Shares	13,317	$0	26,632	D
Phantom Share Units	(4)	01/21/2026		M			3,329	(6)	01/21/2028	Common Shares	3,329	(4)	6,658	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 21, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Viemed Healthcare (VMD) report for CFO Fitzgerald Trae?

The filing shows that CFO Fitzgerald Trae had 13,317 restricted stock units vest into common shares and 3,329 phantom share units vest under the company’s Phantom Share Unit Plan on January 21, 2026.

How many Viemed Healthcare (VMD) common shares does the CFO hold after these transactions?

After the reported transactions on January 21, 2026, Fitzgerald Trae directly holds 98,523 common shares of Viemed Healthcare.

Why were some Viemed Healthcare (VMD) shares withheld in the CFO’s Form 4?

The filing states that 4,246 common shares were withheld by Viemed Healthcare to satisfy tax obligations arising from the vesting of restricted stock units, using a value based on the January 21, 2026 closing price of $7.49 per share.

What are the terms of the CFO’s restricted stock units at Viemed Healthcare (VMD)?

The restricted stock units were granted on January 21, 2025 and vest in three equal annual installments starting on the first anniversary of the grant date. Each RSU represents the right to receive one common share.

What does the Viemed Healthcare (VMD) Phantom Share Unit Plan provide to the CFO?

Under the Phantom Share Unit Plan, each phantom share unit is the economic equivalent of one common share and is settled in cash. The award granted on January 21, 2025 also vests in three equal annual installments starting on the first anniversary of the grant date.

How many derivative units does the Viemed Healthcare (VMD) CFO hold after this filing?

Following the reported activity, Fitzgerald Trae holds 26,632 restricted stock units and 6,658 phantom share units, each referencing one Viemed Healthcare common share.